Catalent reports second-quarter revenue slightly above estimates

Catalent

09/02/2024 13:03

Feb 9 (Reuters) - Catalent  CTLT.N  reported quarterly
revenue that came in slightly above Wall Street estimates on
Friday, days after the contract drug manufacturer agreed to a
$16.5-billion acquisition offer from Novo Nordisk's  NOVOb.CO 
parent firm. 
    Revenue for the second quarter was $1.03 billion, compared
to analysts' estimate of $1.01 billion, according to LSEG data,
helped by improved production across Catalent's key facilities.
   

    

    

        
  
    
    
    

 (Reporting by Sriparna Roy and Bhanvi Satija in Bengaluru;
Editing by Pooja Desai)
 ((Sriparna.Roy@thomsonreuters.com;))